Narrow-moat Icon reported strong first-quarter results highlighted by revenue exceeding $2 billion, representing a nearly 6% increase from the prior-year period, thanks to stabilizing demand within ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how ...
Drawbacks to biotech funding or declines in outsourcing penetration rates could have a material impact on Icon's growth. Icon could fail to innovate and keep an edge over regional and global CRO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback